Wall Street Associates’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Wall Street Associates’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.12M	Sell	12,100 -4,422	-27%	-$498K	0.74%	53
2016 Q3	$2.23M	Buy	16,522 +7,744	+88%	+$769K	0.76%	53
2016 Q2	$890K	Hold	8,778	–	–	0.36%	100
2016 Q1	$1.44M	Hold	8,778	–	–	0.6%	71
2015 Q4	$2.88M	Sell	8,778 -5,000	-36%	-$1.63M	0.81%	28
2015 Q3	$4.44M	Sell	13,778 -9,900	-42%	-$4.35M	0.85%	28
2015 Q2	$9.43M	Sell	23,678 -5,100	-18%	-$2.17M	0.89%	30
2015 Q1	$14.2M	Sell	28,778 -611	-2%	-$237K	1.34%	7
2014 Q4	$10.5M	Sell	29,389 -67	-0.2%	-$19.9K	1.01%	16
2014 Q3	$5.68M	Sell	29,456 -1,911	-6%	-$420K	0.59%	60
2014 Q2	$7.5M	Buy	31,367 +34	+0.1%	+$6.91K	0.64%	52
2014 Q1	$8.01M	Sell	31,333 -8,767	-22%	-$2.68M	0.65%	51
2013 Q4	$7.94M	Buy	40,100 +1,233	+3%	+$219K	0.65%	45
2013 Q3	$6.57M	Sell	38,867 -433	-1%	-$69.7K	0.61%	47
2013 Q2	$6.97M	Buy	+39,300	New	+$5.57M	0.71%	40

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wall Street Associates's LUMO Position: Q4 2016 in Review

Wall Street Associates reduced its Lumos Pharma, Inc. Common Stock (LUMO) stake by 27% in Q4 2016, selling an estimated $498K and leaving 12,100 shares worth $1.12M. The position accounts for 0.74% of the portfolio, ranked #53.

Wall Street Associates first reported a position in LUMO in Q2 2013 and has held it in 15 quarters since. The position peaked at $14.2M in Q1 2015. 122 funds tracked by Wall St. Rank hold LUMO as of Q4 2016.

Wall Street Associates held 12,100 shares of Lumos Pharma, Inc. Common Stock worth $1.12M as of Q4 2016.
Wall Street Associates sold 4,422 Lumos Pharma, Inc. Common Stock shares in Q4 2016, an estimated $498K.
Lumos Pharma, Inc. Common Stock made up 0.74% of Wall Street Associates's portfolio in Q4 2016, its #53 holding.
Wall Street Associates first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
Wall Street Associates's Lumos Pharma, Inc. Common Stock position peaked at $14.2M in Q1 2015.
122 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.